Immunohistochemical (IHC) Scoring for Receptors Expression in Breast Tissues
Sponsor
Applied Spectral Imaging Ltd. (Industry)
Overall Status
Withdrawn
CT.gov ID
NCT00978276
Collaborator
(none)
0
Study Details
Study Description
Brief Summary
The purpose of this study is the identification and classification of human tissues and cytology specimens and elements therein.
Computer aided technology to assist the pathologists to identify, quantify, characterize and report their findings with regards to one or more diagnoses they should perform. In particular and for example: the scoring of the number of elements and their protein (antibody) expression level within a paraffin embedded tissue section.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
0 participants
Observational Model:
Case-Control
Time Perspective:
Retrospective
Official Title:
Concordance Study for Over Expression Level of Antibodies Within Breast Tissues
Study Start Date
:
May 1, 2006
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
20 Years
and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Well stained paraffin embedded tissue specimens
Exclusion Criteria:
- Fade away slides
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Applied Spectral Imaging Ltd.
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00978276
Other Study ID Numbers:
- ASI-IHC
First Posted:
Sep 16, 2009
Last Update Posted:
Jan 5, 2016
Last Verified:
Jan 1, 2016
Keywords provided by ,
,